Prelude Therapeutics Inc (PRLD) Corporate Subsidiaries
Prelude Therapeutics Inc (PRLD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PRLD
CIK: 1678660
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBryan Snellman
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-10 | 2026-09-10 | 8-K | 0001193125-26-387232 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343475 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343469 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-08 | — | SCHEDULE 13G Filing | 0001213900-26-076456 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-265965 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | PRIMARY DOCUMENT | 0001617541-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | PRIMARY DOCUMENT | 0001435618-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | PRIMARY DOCUMENT | 0001572451-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | PRIMARY DOCUMENT | 0001620368-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | PRIMARY DOCUMENT | 0001236927-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-09 | 8-K | 0001193125-26-265835 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-218173 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-218162 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | PRIMARY DOCUMENT | 0001489966-26-000004 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001193125-26-191603 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001193125-26-191565 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-09 | DEF 14A | 0001193125-26-191532 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-28 | — | SCHEDULE 13G Filing | 0001346824-26-000121 | View SEC Doc Filr Page |
| 4 | 2026-04-28 | 2026-04-27 | 4 Filing | 0001231919-26-000422 | View SEC Doc Filr Page |
| 3 | 2026-04-28 | 2026-04-21 | 3 Filing | 0001231919-26-000420 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-23 | — | SCHEDULE 13D/A Filing | 0000947871-26-000463 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-21 | 4 Filing | 0000947871-26-000462 | View SEC Doc Filr Page |
| 4 | 2026-04-23 | 2026-04-21 | 4 Filing | 0000947871-26-000461 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-22 | — | SCHEDULE 13D/A Filing | 0001104659-26-046848 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-21 | 4 | 0001193125-26-170468 | View SEC Doc Filr Page |